NCT00002422View on ClinicalTrials.gov

A Study on the Safety and Anti-HIV Activity of HE2000 in HIV-Infected Patients on Salvage Therapy

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

HE2000

Trial Locations (6)

10011

St Vincents Hosp / Clinical Research Program, New York

60611

Northwestern Univ Med School, Chicago

77004

Plaza Med Ctr, Houston

92262

ViRx Inc, Palm Springs

94115

Quest Clinical Research, San Francisco

94304

Veterans Affairs Palo Alto Health Care Ctr, Palo Alto

Sponsors
All Listed Sponsors
lead

Harbor Therapeutics

INDUSTRY

NCT00002422 - A Study on the Safety and Anti-HIV Activity of HE2000 in HIV-Infected Patients on Salvage Therapy | Biotech Hunter | Biotech Hunter